• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Primary thromboprophylaxis in a patient with type 3 von Willebrand disease and severe COVID-19 infection.

作者信息

Vagrecha Anshul, Stanco Joseph, Majeed Sumreen, Kouides Peter, Acharya Suchitra S

机构信息

Division of Hematology/Oncology and Cellular Therapy, Department of Pediatrics, Cohen Children's Medical Center, New Hyde Park, NY, USA.

Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA.

出版信息

Haemophilia. 2021 Jul;27(4):e517-e519. doi: 10.1111/hae.14252. Epub 2021 Jan 11.

DOI:10.1111/hae.14252
PMID:33427345
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8014028/
Abstract
摘要

相似文献

1
Primary thromboprophylaxis in a patient with type 3 von Willebrand disease and severe COVID-19 infection.3型血管性血友病合并重症新型冠状病毒肺炎感染患者的一级血栓预防
Haemophilia. 2021 Jul;27(4):e517-e519. doi: 10.1111/hae.14252. Epub 2021 Jan 11.
2
Thromboembolic Disease in Patients With Cancer and COVID-19: Risk Factors, Prevention and Practical Thromboprophylaxis Recommendations-State-of-the-Art.癌症合并 COVID-19 患者的血栓栓塞性疾病：风险因素、预防和实用的血栓预防推荐建议——最新进展。
Anticancer Res. 2022 Jul;42(7):3261-3274. doi: 10.21873/anticanres.15815.
3
Systemic thrombosis in a large cohort of COVID-19 patients despite thromboprophylaxis: A retrospective study.尽管进行了血栓预防，但在大型 COVID-19 患者队列中仍发生全身性血栓：一项回顾性研究。
Thromb Res. 2021 Mar;199:132-142. doi: 10.1016/j.thromres.2020.12.024. Epub 2021 Jan 7.
4
Thromboprophylaxis in patients with multiple organ injuries--is there an alternative to low-molecular-weight heparins (LMWH)?多器官损伤患者的血栓预防——低分子量肝素（LMWH）是否有替代药物？
Ortop Traumatol Rehabil. 2011 May-Jun;13(3):229-40.
5
COVID-19 and thrombosis: Prophylaxis and management.2019冠状病毒病与血栓形成：预防与管理
Tuberk Toraks. 2021 Jun;69(2):269-278. doi: 10.5578/tt.20219818.
6
Ethnic differences in thromboprophylaxis for COVID-19 patients: should they be considered?COVID-19 患者的血栓预防存在种族差异：是否应该考虑这些差异？
Int J Hematol. 2021 Mar;113(3):330-336. doi: 10.1007/s12185-021-03078-x. Epub 2021 Jan 20.
7
Antithrombotic prophylaxis in children and adolescents' patients with SARS-CoV-2 (COVID-19) infection: A practical guidance for clinicians.儿童和青少年 SARS-CoV-2（COVID-19）感染患者的抗血栓预防：临床医生实用指南。
Acta Biomed. 2020 Nov 10;91(4):e2020170. doi: 10.23750/abm.v91i4.10720.
8
PICO Questions and DELPHI Methodology for the Management of Venous Thromboembolism Associated with COVID-19.用于管理 COVID-19 相关静脉血栓栓塞症的 PICO 问题和 DELPHI 方法学。
Viruses. 2021 Oct 22;13(11):2128. doi: 10.3390/v13112128.
9
Thrombin generation in patients with COVID-19 with and without thromboprophylaxis.COVID-19 患者伴或不伴血栓预防的凝血酶生成。
Clin Chem Lab Med. 2021 Feb 4;59(7):1323-1330. doi: 10.1515/cclm-2021-0108. Print 2021 Jun 25.
10
Incidence of thrombotic complications in hospitalised and non-hospitalised patients after COVID-19 diagnosis.COVID-19 诊断后住院和非住院患者的血栓并发症发生率。
Br J Haematol. 2021 Aug;194(3):542-546. doi: 10.1111/bjh.17522. Epub 2021 May 24.